"Nerve Growth Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Factors which enhance the growth potentialities of sensory and sympathetic nerve cells.
| Descriptor ID |
D009414
|
| MeSH Number(s) |
D12.644.276.860 D12.776.467.860 D12.776.631.600 D23.529.850
|
| Concept/Terms |
Nerve Growth Factors- Nerve Growth Factors
- Factors, Nerve Growth
- Neurotrophic Proteins
- Neurotrophic Factors
- Factors, Neurotrophic
- Neurotrophins
- Neuronotrophic Factors
- Factors, Neuronotrophic
- Neurotrophic Protein
Growth-Associated Proteins, Neuronal- Growth-Associated Proteins, Neuronal
- Growth Associated Proteins, Neuronal
- Proteins, Neuronal Growth-Associated
- Neuronal Growth-Associated Proteins
- Neuronal Growth Associated Proteins
|
Below are MeSH descriptors whose meaning is more general than "Nerve Growth Factors".
Below are MeSH descriptors whose meaning is more specific than "Nerve Growth Factors".
This graph shows the total number of publications written about "Nerve Growth Factors" by people in this website by year, and whether "Nerve Growth Factors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 2 | 0 | 2 |
| 2003 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nerve Growth Factors" by people in Profiles.
-
Associations of VGF with Neuropathologies and Cognitive Health in Older Adults. Ann Neurol. 2023 08; 94(2):232-244.
-
Targeting neurotrophic factors: Novel approaches to musculoskeletal pain. Pharmacol Ther. 2020 07; 211:107553.
-
Disease Modification Through Trophic Factor Delivery. Methods Mol Biol. 2018; 1780:525-547.
-
PEDF inhibits pancreatic tumorigenesis by attenuating the fibro-inflammatory reaction. Oncotarget. 2016 May 10; 7(19):28218-34.
-
HMG-CoA Reductase Inhibitors Bind to PPARa to Upregulate Neurotrophin Expression in the Brain and Improve Memory in Mice. Cell Metab. 2015 Aug 04; 22(2):253-65.
-
Neurotrophic factor therapy for Parkinson's disease. Prog Brain Res. 2010; 184:237-64.
-
GFAP knockout mice have increased levels of GDNF that protect striatal neurons from metabolic and excitotoxic insults. J Comp Neurol. 2003 Jun 30; 461(3):307-16.
-
Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration. J Neurosci. 2002 Jun 15; 22(12):4942-54.
-
Neuroprotection for Parkinson's disease using viral vector-mediated delivery of GDNF. Prog Brain Res. 2002; 138:421-32.
-
Intrastriatal infusions of brain-derived neurotrophic factor: retrograde transport and colocalization with dopamine containing substantia nigra neurons in rat. Exp Neurol. 1994 Sep; 129(1):15-26.